Pedro Miguel Coutinho Da Costa PhD

Pedro is a Sir Henry Wellcome Postdoctoral fellow, having joined King’s College London in 2014. His research is focused on the synthesis/functionalisation of carbon-based nanocarriers for delivery of miRNAs and CRISPR/Cas9 to the brain. Pedro is also using CRISPR/Cas9 to investigate therapeutic synergies between oncogene knockout and chemotherapeutics in brain cancer stem cells. He has a Bachelor degree (B.Sc) in Biochemistry and a Doctoral degree (Ph.D) in Biochemical Technology from the University of Coimbra (Portugal), during which he worked on the development of gene therapy strategies for treatment of malignant brain tumours, combining lipid-mediated miRNA silencing with tyrosine kinase inhibitors.